Co-Authors
This is a "connection" page, showing publications co-authored by Chun Chao and Erin Hahn.
Connection Strength
4.721
-
Locally-tailored vs. centrally-administered strategies for implementation of primary human papillomavirus (HPV) screening in an integrated healthcare system: a qualitative research study. Front Health Serv. 2025; 5:1595934.
Score: 0.913
-
Trends in HPV vaccine administration and HPV vaccine coverage in children by race/ethnicity and socioeconomic status during the COVID-19 pandemic in an integrated health care system in California. Vaccine. 2022 11 02; 40(46):6575-6580.
Score: 0.753
-
De-implementation and substitution of clinical care processes: stakeholder perspectives on the transition to primary human papillomavirus (HPV) testing for cervical cancer screening. Implement Sci Commun. 2021 Sep 23; 2(1):108.
Score: 0.701
-
Use of recommended posttreatment services for adolescent and young adult survivors of Hodgkin lymphoma. Cancer. 2019 May 01; 125(9):1558-1567.
Score: 0.581
-
Burden of hospitalizations in four adolescent and young adult (AYA) cancer survivor populations in the United States, 2006-2020. Cancer Epidemiol Biomarkers Prev. 2026 Oct 15.
Score: 0.249
-
A pragmatic randomized trial to compare strategies for implementing?primary HPV testing for routine cervical cancer screening in a large?healthcare system. Implement Sci. 2025 May 12; 20(1):21.
Score: 0.226
-
Evaluating the trend of time to colposcopy follow-up among women with a positive primary human papillomavirus screening result at Kaiser Permanente Southern California. Am J Obstet Gynecol. 2025 Mar 27.
Score: 0.224
-
Primary Human Papillomavirus Screening: Women's Perceptions of New Cervical Cancer Screening Recommendations. J Womens Health (Larchmt). 2024 Dec; 33(12):1614-1624.
Score: 0.215
-
A study protocol for a cluster randomized pragmatic trial for comparing strategies for implementing primary HPV testing for routine cervical cancer screening in a large health care system. Contemp Clin Trials. 2023 01; 124:106994.
Score: 0.189
-
Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21-65 Years in a Large Integrated Health Care System - Southern California, January 1-September 30, 2019, and January 1-September 30, 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 29; 70(4):109-113.
Score: 0.168
-
Preventive health service use among survivors of adolescent and young adult cancer. Prev Med Rep. 2020 Dec; 20:101278.
Score: 0.166
-
Adherence to cardiomyopathy screening guidelines among adolescent and young adult cancer survivors exposed to chest radiation and/or anthracyclines. J Cancer Surviv. 2020 Nov 10.
Score: 0.165
-
Metastatic Recurrence Among Adolescents and Young Adults With Cancer. JAMA Oncol. 2026 01 01; 12(1):75-83.
Score: 0.059
-
Trastuzumab therapy and new-onset hypertension in adolescents and young adults with breast cancer. Breast Cancer Res Treat. 2025 Aug; 213(1):81-92.
Score: 0.057
-
Cervical Cancer Screening: Patient Perspectives on Transitioning to Primary High-Risk Human Papillomavirus Testing Alone. Perm J. 2024 Oct 24; 1-8.
Score: 0.054